Your browser doesn't support javascript.
loading
Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.
Nagakura, Tomokazu; Wakiguchi, Hiroyuki; Kubota, Tomohiro; Yamatou, Tsuyoshi; Yamasaki, Yuichi; Nonaka, Yukiko; Nerome, Yasuhito; Akaike, Harumi; Takezaki, Tomoko; Imanaka, Hiroyuki; Kawano, Yoshifumi; Takei, Syuji.
Affiliation
  • Nagakura T; The Holy Mother of Grace Hospital Home for Children and Persons with Severe Motor and Intellectual Disabilities, Usuki.
  • Wakiguchi H; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, and Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube; hiroyuki@yamaguchi-u.ac.jp.
  • Kubota T; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Yamatou T; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Yamasaki Y; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Nonaka Y; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Nerome Y; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Akaike H; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Takezaki T; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Imanaka H; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Kawano Y; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima.
  • Takei S; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, and School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. This work was supported by a Health Labor Sciences Research Grant from the Ministry of Health, Labor a
J Rheumatol ; 44(4): 536-538, 2017 04.
Article in En | MEDLINE | ID: mdl-28604349
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Synovitis / Uveitis / Biological Products / Tumor Necrosis Factor-alpha / Adalimumab / Infliximab / Etanercept / Anti-Inflammatory Agents Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Rheumatol Year: 2017 Document type: Article Country of publication: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Synovitis / Uveitis / Biological Products / Tumor Necrosis Factor-alpha / Adalimumab / Infliximab / Etanercept / Anti-Inflammatory Agents Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Rheumatol Year: 2017 Document type: Article Country of publication: Canada